Meta-analytic results indicate that IL-6 is the most sensitive inflammatory marker that predicts subsequent diabetes in initially healthy samples [10], and concentrations of IL-6 are elevated in patients with type 2 diabetes [13]. This evidence concerns the gene IL6 and diabetes mellitus.